The uses of intravenous immune globulin in collagen vascular disorders.

[1]  L. Caliguiri,et al.  Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy. , 1988, The Journal of pediatrics.

[2]  W. White,et al.  Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. , 1987, The American journal of medicine.

[3]  J. Randolph,et al.  Subclinical autoimmune disease and recurrent spontaneous abortion. , 1986, The Journal of rheumatology.

[4]  J. Newburger,et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .

[5]  J. Scott,et al.  Obstetric complications associated with the lupus anticoagulant. , 1985, The New England journal of medicine.

[6]  G. Liggins,et al.  FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT , 1983, The Lancet.

[7]  C. Cunningham-Rundles,et al.  Antinuclear antibody staining only centrioles in a patient with scleroderma. , 1982 .

[8]  A. Hirt,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.

[9]  Steĭnberg Ad,et al.  Lymphocytes and lymphocyte functions in systemic lupus erythematosus. , 1979, Seminars in hematology.

[10]  P. Disler,et al.  Lack of suppressor cell activity in systemic lupus erythematosus. , 1979, Clinical immunology and immunopathology.

[11]  D. Kaufman,et al.  Defective suppressor T-cell activity in systemic lupus erythematosus. , 1979, Clinical immunology and immunopathology.

[12]  B. Bresnihan,et al.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. , 1977, The Journal of clinical investigation.

[13]  J. Hébert,et al.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. , 1976, Clinical immunology and immunopathology.